ClearPoint Neuro (CLPT) Return on Capital Employed (2012 - 2026)
ClearPoint Neuro (CLPT) posted Return on Capital Employed of 30.75% for Q1 2026, up 13.09% sequentially from 35.39% in Q4 2025, and up 4734.0% YoY from 0.64% in Q1 2025.
ClearPoint Neuro (CLPT) Return on Capital Employed (2012 - 2026) Analysis & Trends
ClearPoint Neuro has reported Return on Capital Employed for 14 years, with the latest figure at 30.75% in Q1 2026.
- Quarterly Return on Capital Employed rose 4734.0% year-over-year to 30.75% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 30.75% (up 4734.0% YoY) and the FY2025 annual result came in at 41.88%, up 2267.0% from the prior year.
- Return on Capital Employed grew to 30.75% in Q1 2026 per CLPT's latest filing, from 35.39% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 25.22% in Q1 2022 and troughed at 78.09% in Q1 2025.
- A 5-year average of 46.91% and a median of 48.43% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed sank 2989 bps in 2023, then surged 4734 bps in 2026.
- Over 5 years, Return on Capital Employed stood at 32.78% in 2022, then slumped by 91 bps to 62.67% in 2023, then retreated by 7 bps to 67.26% in 2024, then surged by 47 bps to 35.39% in 2025, then climbed by 13 bps to 30.75% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 30.75%, 35.39%, and 42.49% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | ClearPoint Neuro | 465.92 Mn | 436.52 Mn | 6.71 Mn | -38.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.92% |
| Mar 31, 2026 | -30.75% |
| Dec 31, 2025 | -35.39% |
| Sep 30, 2025 | -42.49% |
| Jun 30, 2025 | -57.94% |
| Mar 31, 2025 | -78.09% |
| Dec 31, 2024 | -67.26% |
| Sep 30, 2024 | -48.43% |
| Jun 30, 2024 | -50.93% |
| Mar 31, 2024 | -63.50% |
| Dec 31, 2023 | -62.67% |
| Sep 30, 2023 | -55.32% |
| Jun 30, 2023 | -49.38% |
| Mar 31, 2023 | -38.83% |
| Dec 31, 2022 | -32.78% |
| Sep 30, 2022 | -29.96% |
| Jun 30, 2022 | -28.55% |
| Mar 31, 2022 | -25.22% |
| Dec 31, 2021 | -21.44% |
| Sep 30, 2021 | -17.68% |